• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

regulatory

photo of a pair of hands that show the skin condition vitiligo
Pharma

Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie

Pfizer is headed to regulators with results from a pair of late-stage studies testing its would-be Opzelura rival Litfulo in nonsegmental vitiligo.
Fraiser Kansteiner Jul 30, 2026 2:15pm
Floodgate floodgates

Cellares' recent wins have opened the floodgates for the IDMO

Jul 14, 2026 10:26am
Evolution step-up growth trajectory upward trajectory

How biosimilar developers are embracing next phase of US market

Jul 6, 2026 10:03am
European Union flag

Europe's CHMP reverses endorsement of Amgen's Tavneos

Jun 26, 2026 11:07am
Layoffs

ADC plots 17% staff cuts amid Zynlonta safety concerns

Jun 24, 2026 10:19am
cell therapy oncology cancer CAR-T cells

Cellares, Ori dominate automated cell therapy production: report

Jun 18, 2026 10:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings